Abstract
Anti-transglutaminase antibodies are the diagnostic marker of celiac disease, and are considered to be synthesized only by intestinal B-lymphocytes. During an infectious disease, these antibodies are transiently detected in serum. We show that these infection-triggered antibodies may not originate in the intestinal mucosa and are not an indication of celiac disease.
Trial registration:
ClinicalTrials.gov NCT00677495.
Copyright © 2015 Elsevier Inc. All rights reserved.
Publication types
-
Case Reports
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Autoantibodies / blood*
-
Celiac Disease / diagnosis
-
Celiac Disease / enzymology*
-
Celiac Disease / immunology
-
Child, Preschool
-
Diagnosis, Differential
-
Enzyme-Linked Immunosorbent Assay
-
Female
-
GTP-Binding Proteins / blood
-
GTP-Binding Proteins / immunology*
-
Humans
-
Intestinal Mucosa / immunology*
-
Intestinal Mucosa / pathology
-
Male
-
Protein Glutamine gamma Glutamyltransferase 2
-
Transglutaminases / blood
-
Transglutaminases / immunology*
Substances
-
Autoantibodies
-
Protein Glutamine gamma Glutamyltransferase 2
-
Transglutaminases
-
GTP-Binding Proteins
Associated data
-
ClinicalTrials.gov/NCT00677495